# Marianne Pavel

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/marianne-pavel/

## Facts

| Field | Value |
| --- | --- |
| Citations | 15,559 |
| Field | Neuroendocrine Tumor Research Advances |
| h-index | 38 |
| i10-index | 79 |
| Last Known Institution | Friedrich-Alexander-Universität Erlangen-Nürnberg |
| OpenAlex ID | https://openalex.org/A5112705594 |
| Works | 208 |

## Researcher papers

- [Everolimus for Advanced Pancreatic Neuroendocrine Tumors](https://scholariq.org/papers/everolimus-for-advanced-pancreatic-neuroendocrine-tumors/)
- [Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors](https://scholariq.org/papers/lanreotide-in-metastatic-enteropancreatic-neuroendocrine-tumors/)
- [Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-for-the-treatment-of-advanced-non-functional-neuroendocrine-tumours/)
- [Gastroenteropancreatic neuroendocrine neoplasms: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up](https://scholariq.org/papers/gastroenteropancreatic-neuroendocrine-neoplasms-esmo-clinical-practice/)
- [Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome (RADIANT-2): a randomised, placebo-controlled, phase 3 study](https://scholariq.org/papers/everolimus-plus-octreotide-long-acting-repeatable-for-the-treatment-of-advanced/)
- [ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site](https://scholariq.org/papers/enets-consensus-guidelines-update-for-the-management-of-distant-metastatic/)
- [Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids](https://scholariq.org/papers/pulmonary-neuroendocrine-carcinoid-tumors-european-neuroendocrine-tumor-society/)
- [Review article: somatostatin analogues in the treatment of gastroenteropancreatic neuroendocrine (carcinoid) tumours](https://scholariq.org/papers/review-article-somatostatin-analogues-in-the-treatment-of-gastroenteropancreatic/)
- [Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome](https://scholariq.org/papers/telotristat-ethyl-a-tryptophan-hydroxylase-inhibitor-for-the-treatment-of/)
- [Neuroendocrine tumors of midgut and hindgut origin: Tumor‐node‐metastasis classification determines clinical outcome](https://scholariq.org/papers/neuroendocrine-tumors-of-midgut-and-hindgut-origin-tumor-node-metastasis/)
- [Cardiac surgery for carcinoid heart disease in 12 cases](https://scholariq.org/papers/cardiac-surgery-for-carcinoid-heart-disease-in-12-cases/)

## Researcher topics

- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Neuroblastoma Research and Treatments](https://scholariq.org/topics/neuroblastoma-research-and-treatments/)
- [Pancreatic and Hepatic Oncology Research](https://scholariq.org/topics/pancreatic-and-hepatic-oncology-research/)
- [Pituitary Gland Disorders and Treatments](https://scholariq.org/topics/pituitary-gland-disorders-and-treatments/)

## Researcher university

- [Friedrich-Alexander-Universität Erlangen-Nürnberg](https://scholariq.org/institutions/friedrich-alexander-universitat-erlangen-nurnberg/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.